Latest News
April 25, 2019
Circulating tumor cells predict NSCLC survival, but clinical role uncertain
April 25, 2019
MDedge Hematology and Oncology
April 25, 2019
BWH classification system better predicts outcomes in HNCSCC
April 25, 2019
MDedge Hematology and Oncology
April 25, 2019
TTP death linked to elevated troponin and neurological signs
April 25, 2019
MDedge Hematology and Oncology
Hem-Onc Board Review
Clinical Reviews
April 3, 2019
Management of Castration-Resistant Prostate Cancer
April 3, 2019
MDedge Hematology and Oncology
February 14, 2019
Chronic Myeloid Leukemia: A Review of TKI Therapy
February 14, 2019
MDedge Hematology and Oncology
February 6, 2019
Chronic Myeloid Leukemia: Evaluation and Diagnosis
February 6, 2019
MDedge Hematology and Oncology
January 18, 2019
Aplastic Anemia: Evaluation and Diagnosis
January 18, 2019
MDedge Hematology and Oncology
Conference Coverage
April 25, 2019
Circulating tumor cells predict NSCLC survival, but clinical role uncertain
April 25, 2019
MDedge Hematology and Oncology
April 25, 2019
TTP death linked to elevated troponin and neurological signs
April 25, 2019
MDedge Hematology and Oncology
April 24, 2019
High-dose MTX-based chemo is well tolerated in older PCNSL patients
April 24, 2019
MDedge Hematology and Oncology
Business of Medicine
April 24, 2019
Report: Part B funds stable, hospital trust running out
April 24, 2019
MDedge Hematology and Oncology
April 23, 2019
Beyond disclosure: Industry relationships face renewed scrutiny in oncology
April 23, 2019
MDedge Hematology and Oncology
April 19, 2019
CMS plan will incentivize generic drug use
April 19, 2019
MDedge Hematology and Oncology
FDA/CDC
April 24, 2019
CDC warns against misuse of opioid-prescribing guideline
April 24, 2019
MDedge Hematology and Oncology
April 15, 2019
2018 at a glance: Recently approved therapies in oncology
April 15, 2019
MDedge Hematology and Oncology
April 15, 2019
CDC clarifies opioid prescribing guidelines in cancer, sickle cell disease
April 15, 2019
MDedge Hematology and Oncology
April 12, 2019
FDA approves pembrolizumab for first-line stage III NSCLC
April 12, 2019
MDedge Hematology and Oncology
Perspectives
April 8, 2019
Is childhood cancer associated with assisted reproductive technology?
April 8, 2019
MDedge Hematology and Oncology
April 4, 2019
Powerful breast-implant testimony constrained by limited evidence
April 4, 2019
MDedge Hematology and Oncology
March 29, 2019
Who’s increasing health care costs? Not us!
March 29, 2019
MDedge Hematology and Oncology
Hematology
April 25, 2019
TTP death linked to elevated troponin and neurological signs
April 25, 2019
MDedge Hematology and Oncology
April 24, 2019
CDC warns against misuse of opioid-prescribing guideline
April 24, 2019
MDedge Hematology and Oncology
April 24, 2019
Monitoring, early intervention key to CAR T safety
April 24, 2019
MDedge Hematology and Oncology
April 24, 2019
Complementary medicine use common among patients on TKIs
April 24, 2019
MDedge Hematology and Oncology
Follicular Lymphoma
April 8, 2019
In situ vaccination produced responses in indolent NHL
April 8, 2019
MDedge Hematology and Oncology
April 5, 2019
Polatuzumab outperforms pinatuzumab in non-Hodgkin lymphoma
April 5, 2019
MDedge Hematology and Oncology
March 21, 2019
High survival in relapsed FL after primary radiotherapy
March 21, 2019
MDedge Hematology and Oncology
February 11, 2019
Anthracyclines, bendamustine are options for grade 3A follicular lymphoma
February 11, 2019
MDedge Hematology and Oncology
February 11, 2019
Daratumumab disappoints in non-Hodgkin lymphoma trial
February 11, 2019
MDedge Hematology and Oncology
Breast Cancer
April 24, 2019
Subcutaneous or IV trastuzumab? Take your pick
April 24, 2019
MDedge Hematology and Oncology
April 16, 2019
Novel CAR T, anti-PD-1 combo shows promise in MPD
April 16, 2019
MDedge Hematology and Oncology
April 15, 2019
Immunotherapy overtaking breast cancer treatment landscape
April 15, 2019
MDedge Hematology and Oncology
April 8, 2019
ACP: Average-risk women under 50 can postpone mammogram
April 8, 2019
MDedge Hematology and Oncology
April 4, 2019
FDA approves palbociclib for men with HR+/HER2- advanced breast cancer
April 4, 2019
MDedge Hematology and Oncology